Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema (Q38399368)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
scientific article

    Statements

    Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema (English)
    1 reference
    John A Wells
    1 reference
    Lloyd Paul Aiello
    1 reference
    Andrew N Antoszyk
    1 reference
    Carl W Baker
    1 reference
    David J Browning
    1 reference
    Crystal G Connor
    1 reference
    Michael J Elman
    1 reference
    Frederick L Ferris
    1 reference
    Scott M Friedman
    1 reference
    Michele Melia
    1 reference
    Dante J Pieramici
    1 reference
    Jennifer K Sun
    1 reference
    25 November 2015
    1 reference
    134
    1 reference
    127-134
    1 reference
    2
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit